Opioid-Induced Constipation Market Report

China Opioid-Induced Constipation Industry Market Research Report 2023-2029

  • POSTDATE：Oct 07, 2023
  • PAGES：211
  • REPORT CODE：GMM1834499
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Opioid-Induced Constipation industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • CB Fleet

    • Takeda Pharmaceutical

    • Progenics Pharmaceuticals

    • Daiichi Sankyo

    • Sucampo

    • SLA Pharma

    • Mundipharma

    • Ironwood Pharmaceuticals

    • Bayer

    • Pfizer

    • Shionogi

    • Valeant Pharmaceuticals International

    • Daewoong

    • GlaxoSmithKline

    • Merck

    • Synergy Pharmaceuticals

    • AstraZeneca

    • Nektar Therapeutics

    • Boehringer Ingelheim

    • Cosmo Pharmaceuticals

    By Type:

    • Oral

    • Parenteral

    By Application:

    • Hospital

    • Others

    • Drugstore

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Opioid-Induced Constipation Market Overview 2018-2029

    • 1.1 China Opioid-Induced Constipation Industry Development Overview

    • 1.2 China Opioid-Induced Constipation Industry Development History

    • 1.3 China Opioid-Induced Constipation Industry Market Size (2018-2029)

    • 1.4 China Opioid-Induced Constipation Market Analysis by Type from Production Side

      • 1.4.1 China Opioid-Induced Constipation Production Volume, Production Value and Growth Rate of Oral (2018-2029)

      • 1.4.2 China Opioid-Induced Constipation Production Volume, Production Value and Growth Rate of Parenteral (2018-2029)

    • 1.5 China Opioid-Induced Constipation Market Analysis by Application from Consumption End

      • 1.5.1 China Opioid-Induced Constipation Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

      • 1.5.2 China Opioid-Induced Constipation Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.3 China Opioid-Induced Constipation Sales Volume, Sales Value and Growth Rate of Drugstore (2018-2029)

    • 1.6 China Opioid-Induced Constipation Market Analysis by Region

      • 1.6.1 North China Opioid-Induced Constipation Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Opioid-Induced Constipation Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Opioid-Induced Constipation Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Opioid-Induced Constipation Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Opioid-Induced Constipation Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Opioid-Induced Constipation Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Opioid-Induced Constipation Market Size and Growth Rate from 2018-2029

    Chapter 2 China Opioid-Induced Constipation Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Opioid-Induced Constipation Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Opioid-Induced Constipation Market Status and Competition Analysis in 2023

      • 2.2.3 China Opioid-Induced Constipation Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Opioid-Induced Constipation Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Opioid-Induced Constipation Industry Development

    Chapter 3 Opioid-Induced ConstipationIndustry Chain Analysis

    • 3.1 Opioid-Induced Constipation Industry Chain

    • 3.2 Opioid-Induced Constipation Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Opioid-Induced Constipation Market

    • 3.3 Opioid-Induced Constipation Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Opioid-Induced Constipation Market

    Chapter 4 China Opioid-Induced Constipation Market, by Type

    • 4.1 China Opioid-Induced Constipation Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Opioid-Induced Constipation Total Production Volume and Growth Rate from Production Side

    • 4.5 China Opioid-Induced Constipation Production Volume and Growth Rate, by Type

      • 4.5.1 China Opioid-Induced Constipation Production Volume and Growth Rate of Oral

      • 4.5.2 China Opioid-Induced Constipation Production Volume and Growth Rate of Parenteral

    Chapter 5 China Opioid-Induced Constipation Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Opioid-Induced Constipation Total Market Size and Growth Rate from Consumption End

    • 5.5 China Opioid-Induced Constipation Market Size and Growth Rate, by Application

      • 5.5.1 China Opioid-Induced Constipation Market Size and Growth Rate of Hospital

      • 5.5.2 China Opioid-Induced Constipation Market Size and Growth Rate of Others

      • 5.5.3 China Opioid-Induced Constipation Market Size and Growth Rate of Drugstore

    Chapter 6 China Opioid-Induced Constipation Market, by Region

    • 6.1 China Opioid-Induced Constipation Production Volume and Production Value, by Region

    • 6.2 China Opioid-Induced Constipation Sales Volume and Sales Value, by Region

    Chapter 7 North China Opioid-Induced Constipation Market Analysis

    • 7.1 North China Opioid-Induced Constipation Market, by Type

    • 7.2 North China Opioid-Induced Constipation Market, by Application

    Chapter 8 Central China Opioid-Induced Constipation Market Analysis

    • 8.1 Central China Opioid-Induced Constipation Market, by Type

    • 8.2 Central China Opioid-Induced Constipation Market, by Application

    Chapter 9 South China Opioid-Induced Constipation Market Analysis

    • 9.1 South China Opioid-Induced Constipation Market, by Type

    • 9.2 South China Opioid-Induced Constipation Market, by Application

    Chapter 10 East China Opioid-Induced Constipation Market Analysis

    • 10.1 East China Opioid-Induced Constipation Market, by Type

    • 10.2 East China Opioid-Induced Constipation Market, by Application

    Chapter 11 Northeast China Opioid-Induced Constipation Market Analysis

    • 11.1 Northeast China Opioid-Induced Constipation Market, by Type

    • 11.2 Northeast China Opioid-Induced Constipation Market, by Application

    Chapter 12 Southwest China Opioid-Induced Constipation Market Analysis

    • 12.1 Southwest China Opioid-Induced Constipation Market, by Type

    • 12.2 Southwest China Opioid-Induced Constipation Market, by Application

    Chapter 13 Northwest China Opioid-Induced Constipation Market Analysis

    • 13.1 Northwest China Opioid-Induced Constipation Market, by Type

    • 13.2 Northwest China Opioid-Induced Constipation Market, by Application

    Chapter 14 Company Profiles

      • 14.1 CB Fleet

        • 14.1.1 CB Fleet Company Profile

        • 14.1.2 CB Fleet Opioid-Induced Constipation Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Takeda Pharmaceutical

        • 14.2.1 Takeda Pharmaceutical Company Profile

        • 14.2.2 Takeda Pharmaceutical Opioid-Induced Constipation Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Progenics Pharmaceuticals

        • 14.3.1 Progenics Pharmaceuticals Company Profile

        • 14.3.2 Progenics Pharmaceuticals Opioid-Induced Constipation Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Daiichi Sankyo

        • 14.4.1 Daiichi Sankyo Company Profile

        • 14.4.2 Daiichi Sankyo Opioid-Induced Constipation Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Sucampo

        • 14.5.1 Sucampo Company Profile

        • 14.5.2 Sucampo Opioid-Induced Constipation Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 SLA Pharma

        • 14.6.1 SLA Pharma Company Profile

        • 14.6.2 SLA Pharma Opioid-Induced Constipation Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Mundipharma

        • 14.7.1 Mundipharma Company Profile

        • 14.7.2 Mundipharma Opioid-Induced Constipation Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Ironwood Pharmaceuticals

        • 14.8.1 Ironwood Pharmaceuticals Company Profile

        • 14.8.2 Ironwood Pharmaceuticals Opioid-Induced Constipation Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Bayer

        • 14.9.1 Bayer Company Profile

        • 14.9.2 Bayer Opioid-Induced Constipation Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Pfizer

        • 14.10.1 Pfizer Company Profile

        • 14.10.2 Pfizer Opioid-Induced Constipation Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Shionogi

        • 14.11.1 Shionogi Company Profile

        • 14.11.2 Shionogi Opioid-Induced Constipation Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Valeant Pharmaceuticals International

        • 14.12.1 Valeant Pharmaceuticals International Company Profile

        • 14.12.2 Valeant Pharmaceuticals International Opioid-Induced Constipation Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Daewoong

        • 14.13.1 Daewoong Company Profile

        • 14.13.2 Daewoong Opioid-Induced Constipation Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 GlaxoSmithKline

        • 14.14.1 GlaxoSmithKline Company Profile

        • 14.14.2 GlaxoSmithKline Opioid-Induced Constipation Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 Merck

        • 14.15.1 Merck Company Profile

        • 14.15.2 Merck Opioid-Induced Constipation Market Performance

        • 14.15.3 Product&Service Introduction

      • 14.16 Synergy Pharmaceuticals

        • 14.16.1 Synergy Pharmaceuticals Company Profile

        • 14.16.2 Synergy Pharmaceuticals Opioid-Induced Constipation Market Performance

        • 14.16.3 Product&Service Introduction

      • 14.17 AstraZeneca

        • 14.17.1 AstraZeneca Company Profile

        • 14.17.2 AstraZeneca Opioid-Induced Constipation Market Performance

        • 14.17.3 Product&Service Introduction

      • 14.18 Nektar Therapeutics

        • 14.18.1 Nektar Therapeutics Company Profile

        • 14.18.2 Nektar Therapeutics Opioid-Induced Constipation Market Performance

        • 14.18.3 Product&Service Introduction

      • 14.19 Boehringer Ingelheim

        • 14.19.1 Boehringer Ingelheim Company Profile

        • 14.19.2 Boehringer Ingelheim Opioid-Induced Constipation Market Performance

        • 14.19.3 Product&Service Introduction

      • 14.20 Cosmo Pharmaceuticals

        • 14.20.1 Cosmo Pharmaceuticals Company Profile

        • 14.20.2 Cosmo Pharmaceuticals Opioid-Induced Constipation Market Performance

        • 14.20.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Opioid-Induced Constipation Industry Research Conclusions

    • 15.2 Opioid-Induced Constipation Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Opioid-Induced Constipation Industry Market Size (2018-2029)

    • Figure China Opioid-Induced Constipation Production Volume, Production Value and Growth Rate of Oral (2018-2029)

    • Figure China Opioid-Induced Constipation Production Volume, Production Value and Growth Rate of Parenteral (2018-2029)

    • Figure China Opioid-Induced Constipation Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • Figure China Opioid-Induced Constipation Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Opioid-Induced Constipation Sales Volume, Sales Value and Growth Rate of Drugstore (2018-2029)

    • Figure North China Opioid-Induced Constipation Market Size and Growth Rate from 2018-2029

    • Figure Central China Opioid-Induced Constipation Market Size and Growth Rate from 2018-2029

    • Figure South China Opioid-Induced Constipation Market Size and Growth Rate from 2018-2029

    • Figure East China Opioid-Induced Constipation Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Opioid-Induced Constipation Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Opioid-Induced Constipation Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Opioid-Induced Constipation Market Size and Growth Rate from 2018-2029

    • Figure Opioid-Induced Constipation Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Opioid-Induced Constipation Market Share by Type in 2018

    • Figure China Opioid-Induced Constipation Market Share by Type in 2023

    • Figure China Opioid-Induced Constipation Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Opioid-Induced Constipation Production Volume and Growth Rate of Oral (2018-2023)

    • Figure China Opioid-Induced Constipation Production Volume and Growth Rate of Parenteral (2018-2023)

    • Figure China Opioid-Induced Constipation Market Share by Application in 2018

    • Figure China Opioid-Induced Constipation Market Share by Application in 2023

    • Figure China Opioid-Induced Constipation Total Market Size and Growth Rate from Consumption End

    • Figure China Opioid-Induced Constipation Market Size and Growth Rate of Hospital (2018-2023)

    • Figure China Opioid-Induced Constipation Market Size and Growth Rate of Others (2018-2023)

    • Figure China Opioid-Induced Constipation Market Size and Growth Rate of Drugstore (2018-2023)

    • Table China Opioid-Induced Constipation Production Volume by Region (2018-2023)

    • Table China Opioid-Induced Constipation Production Volume Share by Region (2018-2023)

    • Figure China Opioid-Induced Constipation Production Volume Share by Region (2018-2023)

    • Table China Opioid-Induced Constipation Production Value by Region (2018-2023)

    • Table China Opioid-Induced Constipation Production Value Share by Region (2018-2023)

    • Figure China Opioid-Induced Constipation Production Value Share by Region (2018-2023)

    • Table China Opioid-Induced Constipation Sales Volume by Region (2018-2023)

    • Table China Opioid-Induced Constipation Sales Volume Share by Region (2018-2023)

    • Figure China Opioid-Induced Constipation Sales Volume Share by Region (2018-2023)

    • Table China Opioid-Induced Constipation Sales Value by Region (2018-2023)

    • Table China Opioid-Induced Constipation Sales Value Share by Region (2018-2023)

    • Figure China Opioid-Induced Constipation Sales Value Share by Region (2018-2023)

    • Table North China Opioid-Induced Constipation Production Volume by Type (2018-2023)

    • Table North China Opioid-Induced Constipation Production Volume Share by Type (2018-2023)

    • Figure North China Opioid-Induced Constipation Production Volume Share by Type (2018-2023)

    • Table North China Opioid-Induced Constipation Sales Volume by Application (2018-2023)

    • Table North China Opioid-Induced Constipation Sales Volume Share by Application (2018-2023)

    • Figure North China Opioid-Induced Constipation Sales Volume Share by Application (2018-2023)

    • Table Central China Opioid-Induced Constipation Production Volume by Type (2018-2023)

    • Table Central China Opioid-Induced Constipation Production Volume Share by Type (2018-2023)

    • Figure Central China Opioid-Induced Constipation Production Volume Share by Type (2018-2023)

    • Table Central China Opioid-Induced Constipation Sales Volume by Application (2018-2023)

    • Table Central China Opioid-Induced Constipation Sales Volume Share by Application (2018-2023)

    • Figure Central China Opioid-Induced Constipation Sales Volume Share by Application (2018-2023)

    • Table South China Opioid-Induced Constipation Production Volume by Type (2018-2023)

    • Table South China Opioid-Induced Constipation Production Volume Share by Type (2018-2023)

    • Figure South China Opioid-Induced Constipation Production Volume Share by Type (2018-2023)

    • Table South China Opioid-Induced Constipation Sales Volume by Application (2018-2023)

    • Table South China Opioid-Induced Constipation Sales Volume Share by Application (2018-2023)

    • Figure South China Opioid-Induced Constipation Sales Volume Share by Application (2018-2023)

    • Table East China Opioid-Induced Constipation Production Volume by Type (2018-2023)

    • Table East China Opioid-Induced Constipation Production Volume Share by Type (2018-2023)

    • Figure East China Opioid-Induced Constipation Production Volume Share by Type (2018-2023)

    • Table East China Opioid-Induced Constipation Sales Volume by Application (2018-2023)

    • Table East China Opioid-Induced Constipation Sales Volume Share by Application (2018-2023)

    • Figure East China Opioid-Induced Constipation Sales Volume Share by Application (2018-2023)

    • Table Northeast China Opioid-Induced Constipation Production Volume by Type (2018-2023)

    • Table Northeast China Opioid-Induced Constipation Production Volume Share by Type (2018-2023)

    • Figure Northeast China Opioid-Induced Constipation Production Volume Share by Type (2018-2023)

    • Table Northeast China Opioid-Induced Constipation Sales Volume by Application (2018-2023)

    • Table Northeast China Opioid-Induced Constipation Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Opioid-Induced Constipation Sales Volume Share by Application (2018-2023)

    • Table Southwest China Opioid-Induced Constipation Production Volume by Type (2018-2023)

    • Table Southwest China Opioid-Induced Constipation Production Volume Share by Type (2018-2023)

    • Figure Southwest China Opioid-Induced Constipation Production Volume Share by Type (2018-2023)

    • Table Southwest China Opioid-Induced Constipation Sales Volume by Application (2018-2023)

    • Table Southwest China Opioid-Induced Constipation Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Opioid-Induced Constipation Sales Volume Share by Application (2018-2023)

    • Table Northwest China Opioid-Induced Constipation Production Volume by Type (2018-2023)

    • Table Northwest China Opioid-Induced Constipation Production Volume Share by Type (2018-2023)

    • Figure Northwest China Opioid-Induced Constipation Production Volume Share by Type (2018-2023)

    • Table Northwest China Opioid-Induced Constipation Sales Volume by Application (2018-2023)

    • Table Northwest China Opioid-Induced Constipation Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Opioid-Induced Constipation Sales Volume Share by Application (2018-2023)

    • Table CB Fleet Company Profile

    • Table CB Fleet Opioid-Induced Constipation Revenue, Price and Gross (2018-2023)

    • Table Takeda Pharmaceutical Company Profile

    • Table Takeda Pharmaceutical Opioid-Induced Constipation Revenue, Price and Gross (2018-2023)

    • Table Progenics Pharmaceuticals Company Profile

    • Table Progenics Pharmaceuticals Opioid-Induced Constipation Revenue, Price and Gross (2018-2023)

    • Table Daiichi Sankyo Company Profile

    • Table Daiichi Sankyo Opioid-Induced Constipation Revenue, Price and Gross (2018-2023)

    • Table Sucampo Company Profile

    • Table Sucampo Opioid-Induced Constipation Revenue, Price and Gross (2018-2023)

    • Table SLA Pharma Company Profile

    • Table SLA Pharma Opioid-Induced Constipation Revenue, Price and Gross (2018-2023)

    • Table Mundipharma Company Profile

    • Table Mundipharma Opioid-Induced Constipation Revenue, Price and Gross (2018-2023)

    • Table Ironwood Pharmaceuticals Company Profile

    • Table Ironwood Pharmaceuticals Opioid-Induced Constipation Revenue, Price and Gross (2018-2023)

    • Table Bayer Company Profile

    • Table Bayer Opioid-Induced Constipation Revenue, Price and Gross (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer Opioid-Induced Constipation Revenue, Price and Gross (2018-2023)

    • Table Shionogi Company Profile

    • Table Shionogi Opioid-Induced Constipation Revenue, Price and Gross (2018-2023)

    • Table Valeant Pharmaceuticals International Company Profile

    • Table Valeant Pharmaceuticals International Opioid-Induced Constipation Revenue, Price and Gross (2018-2023)

    • Table Daewoong Company Profile

    • Table Daewoong Opioid-Induced Constipation Revenue, Price and Gross (2018-2023)

    • Table GlaxoSmithKline Company Profile

    • Table GlaxoSmithKline Opioid-Induced Constipation Revenue, Price and Gross (2018-2023)

    • Table Merck Company Profile

    • Table Merck Opioid-Induced Constipation Revenue, Price and Gross (2018-2023)

    • Table Synergy Pharmaceuticals Company Profile

    • Table Synergy Pharmaceuticals Opioid-Induced Constipation Revenue, Price and Gross (2018-2023)

    • Table AstraZeneca Company Profile

    • Table AstraZeneca Opioid-Induced Constipation Revenue, Price and Gross (2018-2023)

    • Table Nektar Therapeutics Company Profile

    • Table Nektar Therapeutics Opioid-Induced Constipation Revenue, Price and Gross (2018-2023)

    • Table Boehringer Ingelheim Company Profile

    • Table Boehringer Ingelheim Opioid-Induced Constipation Revenue, Price and Gross (2018-2023)

    • Table Cosmo Pharmaceuticals Company Profile

    • Table Cosmo Pharmaceuticals Opioid-Induced Constipation Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US